Your search history is turned on.
Date: May 19, 2016 Jurisdictions: Alberta, British Columbia, Ontario
May 19, 2016 Attorney Appointed to Administer Affairs of Biosign and Manage CTO Toronto, Ontario, May 20, 2016 Biosign Technologies Inc. (TSX.V-NEX BIO.H), (Biosign or the Company). Subsequent to the Companys press release dated April 28th, 2016, stating all directors and officers had resigned from the Company effective immediately, the Ontario Securitie...
Date: April 28, 2016 Jurisdictions: All jurisdictions
Biosign Announces Resignation of All Directors and Officers Biosign Announces Resignation of All Directors and Officers TORONTO, April 28, 2016 /CNW/ - Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company") announces that in furtherance of its press release dated April 13, 2016 whereby Biosign disclosed that it had ceased operations, all of the directors and all officers of the Company ha...
Date: April 13, 2016 Jurisdictions: All jurisdictions
Biosign ceases operations Biosign ceases operations TORONTO, April 13, 2016 /CNW/ - Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company") announces that it has ceased its operations. Quob Park Estates ("QPE") has confirmed that it is no longer willing to advance additional funds to Biosign who cannot meet its ongoing obligations. Over the past 18 months, the Company pursued efforts to...
Date: February 16, 2016 Jurisdictions: Alberta, British Columbia, Ontario
Microsoft Word - Material change report - Biosign Announces Divestiture.docx FORM51102F3 MaterialChangeReport 1.NameandRegisteredAddressofCompany BiosignTechnologiesInc. 10FourSeasonsPlace,Ste1000 Toronto,Ontario M9B6H7 2DateofMaterialChange January22,2016 3.NewsRelease ThenewsreleaseattachedheretoasScheduleAwasissue...
Date: January 22, 2016 Jurisdictions: All jurisdictions
Biosign Announces Proposed Divestiture Biosign Announces Proposed Divestiture TORONTO, Jan. 22, 2016 /CNW/ - Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company") announces that under a letter of intent dated January 21, 2016 ("LOI"), it intends to sell 70% of the shares issued and outstanding of Aiomed as well as 76% of the voting rights ("Aiomed Shares") subject to finalizing a purchas...
Date: January 11, 2016 Jurisdictions: All jurisdictions
Biosign Announces Director Resignation Biosign Announces Director Resignation /CNW/ - Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company") announces that effective January 6, 2016 Brian Neill has tendered his resignation from the Board of Biosign. He states "it is with reluctance that I am now leaving the Board of Biosign, as so much work has been done turning the company around into a...
Date: November 30, 2015 Jurisdictions: Alberta, British Columbia, Ontario
Microsoft Word - CFO Certification - Sept 30, 2015 FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Mario Laflamme, Chief Financial Officer of Biosign Technologies Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Biosign Tec...
Microsoft Word - CEO Certification - Sept 30, 2015 FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Michael Gross, Chief Executive Officer of Biosign Technologies Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Biosign Tech...
Microsoft Word - Biosign MD&A - Sept 30, 2015 - Nov 27 ML 5 pm Germany BIOSIGN TECHNOLOGIES INC. 1000-10 Four Seasons Place, Toronto, Ontario, M9B 6H7 (Address of principal executive offices and postal code) (416) 218-9800 (Telephone Number) Total Common Shares: 22,823,162 Issued and Outstanding As at September 30, 2015 office...
Microsoft Word - Biosign FS - Sept 30, 2015 - Nov 27 ML 5 pm Germany BIOSIGN TECHNOLOGIES INC. CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED) (EXPRESSED IN CANADIAN DOLLARS) FOR THE THREE AND NINE MONTH PERIODS ENDED SEPTEMBER 30, 2015 AND SEPTEMBER 30, 2014 ...